Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Yuhua Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9563-4844; OpenAlex author ID A5100334849. Sources: OpenAlex.

Their work

Papers
22 (first author 0, last author 12)
Trials
0
Grants
0
Labs led
1
Collaborators
35
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 4 papers · 2022: none · 2023: 3 papers · 2024: 2 papers · 2025: 4 papers · 2026: 4 papers

Papers 22

  1. Stiffness-Activated Stellate Cells Drive Pancreatic Cancer Liver Colonization via GMFG-TNS4 Signaling. Last author DOI 10.1002/advs.76173↗
  2. Metabolic plasticity in the pancreatic cancer metastatic cascade. Last author DOI 10.1016/j.bbcan.2026.189622↗
  3. MβCD@HA-Ad nanoparticles inhibit pancreatic cancer progression by targeting Caveolin-1/Piezo1/PLA2G4A-mediated lipid reprogramming. Co-author DOI 10.1016/j.jconrel.2026.115223↗
  4. Circ-0030167/IGF2BP1 Induces Mitophagy-Mediated Ferroptosis via HMOX1 mRNA Stabilization in Pancreatic Cancer. Last author DOI 10.1111/cas.70356↗
  5. 3D pancreatic ductal adenocarcinoma desmoplastic model: Glycolysis facilitating stemness via ITGAV-PI3K-AKT-YAP1. Last author DOI 10.1016/j.bioadv.2025.214215↗
  6. 3D printed GelMA/HAMA based mechanical microenvironment boosted PDAC chemoresistance via NRF2-repressed ferroptosis. Last author DOI 10.1016/j.colsurfb.2025.114816↗
  7. 3D printing-biomimetic local stiff niche enhances glycolysis to boost PDAC cell stem-like phenotype via N6-methyladenosine-suppressed YAP1 mRNA decay. Last author DOI 10.1016/j.mtbio.2025.102176↗
  8. PLAAT2 facilitates the development of pancreatic cancer and serves as a predictor of resistance to chemotherapy. Co-author DOI 10.1186/s12885-025-15481-2↗
  9. Corrigendum to "Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging … Last author DOI 10.1016/j.canlet.2023.216603↗
  10. Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like p… Last author DOI 10.1016/j.ijbiomac.2024.131826↗
  11. Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker. Last author DOI 10.1007/s00432-023-05161-8↗
  12. Biomimetic Microenvironmental Stiffness Boosts Stemness of Pancreatic Ductal Adenocarcinoma via Augmented Autophagy. Last author DOI 10.1021/acsbiomaterials.3c00487↗
  13. COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation. Co-author DOI 10.3390/cancers15051480↗
  14. miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1. Co-author DOI 10.1007/s00066-020-01728-3↗
  15. Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and t… Last author DOI 10.1016/j.canlet.2021.04.030↗
  16. LncRNA TP73-AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through miRNA -200a sponging. Last author DOI 10.1111/jcmm.16425↗
  17. MiR-573 suppresses cell proliferation, migration and invasion via regulation of E2F3 in pancreatic cancer. Co-author DOI 10.7150/jca.51147↗
  18. YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a. Co-author DOI 10.1016/j.yexcr.2017.07.039↗
  19. High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep12991↗
  20. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. Co-author DOI 10.1186/1471-2407-14-85↗
  21. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2013.07.009↗
  22. [Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell]. Co-author PMID 22340650↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yibing Guo · 11 shared papers, 2017–2026 · strength 2.52
  2. Biwen Zhu · 5 shared papers, 2025–2026 · strength 1.57
  3. Xihao Yao · 6 shared papers, 2021–2026 · strength 1.19
  4. Xiaohong Li · 9 shared papers, 2011–2025 · strength 1.14
  5. Jiashuai Yan · 4 shared papers, 2025–2026 · strength 1.07
  6. Xiaoqi Guan · 4 shared papers, 2025–2026 · strength 1.07
  7. Qingsong Guo · 6 shared papers, 2013–2026 · strength 1.02
  8. Qiyang Chen · 3 shared papers, 2023–2026 · strength 0.81
  9. Di Wu · 3 shared papers, 2025 · strength 0.80
  10. Zhiwei Wang · 4 shared papers, 2013–2026 · strength 0.61
  11. Xue Zhang · 2 shared papers, 2025 · strength 0.53
  12. Jingjing Lu · 3 shared papers, 2017–2024 · strength 0.41
  13. Di Wu · 2 shared papers, 2023–2024 · strength 0.39
  14. Tiancheng Gong · 2 shared papers, 2023–2024 · strength 0.39
  15. Zhiwei Wang · 4 shared papers, 2015–2021 · strength 0.37
  16. Pengcheng Zhou · 2 shared papers, 2021–2023 · strength 0.36
  17. Xiaohong Li · 1 shared paper, 2026 · strength 0.33
  18. Qun Zhao · 1 shared paper, 2026 · strength 0.33
  19. Yingqing Mao · 2 shared papers, 2021–2024 · strength 0.33
  20. Lei Wang · 3 shared papers, 2013–2023 · strength 0.31
  21. Yan Xue · 1 shared paper, 2026 · strength 0.30
  22. Dongzhi Wang · 1 shared paper, 2026 · strength 0.30
  23. Xingyu Jiang · 1 shared paper, 2026 · strength 0.30
  24. Yibing Guo · 1 shared paper, 2026 · strength 0.27
  25. Yao Hua Song · 1 shared paper, 2023 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.